Investigating the result of intrauterine insemination with the double trigger of gonadotropin-releasing hormone and recombinant human chorionic gonadotropin agonist.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240514061800N6

Enrollment

322

Registered

2024-10-15

Start date

2024-10-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine insemination. Normal Pregnancy

Interventions

Intervention 1: Intervention group: In this group, ovarian stimulation is done with 5000 units of HCG after the follicle diameter reaches more than 18 mm. Intervention 2: Intervention group: In this g

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients less than 40 years old Patients with unexplained infertility Patients with mild male factors

Exclusion criteria

Exclusion criteria: Endometriosis cyst Severe adenomyosis Severe male infertility with a sperm count of less than 5 million per milliliter

Design outcomes

Primary

Measure	Time frame
Biochemistry Pregnancy. Timepoint: 14 days after the intervention. Method of measurement: Laboratory methods.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTayebe Esfidani

Shahid Beheshti University of Medical Sciences

esfidani.tayebeh@gmail.com+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026